Nasia Safdar, MD
Infectious Disease · Madison, WINPI 1316904071
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.5%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 4 manufacturers reported payments, led by Ferring Pharmaceuticals Inc. at 45.9% of the total. 2023 is the largest year on record at $11,565, more than ten times the $1,060 reported in 2021. Among infectious disease clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 21 payments — averaging $1057.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals Inc.$10K
- Molnlycke Health Care US, LLC$8K
- Aimmune Therapeutics, Inc.$4K
- Promega Corporation$60
Across 6 payments — averaging $22,128 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Rebiotix Inc.$96K
- Ferring Pharmaceuticals AS$37K
What the payments were for
- Consulting fees$9,66344%
- Speaking & faculty fees$3,90718%
- Travel & lodging$8,04136%
- Food & beverage$5663%
- Gifts$250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 15 | $10,194 |
| Molnlycke Health Care US, LLC | 2 | $7,951 |
| Aimmune Therapeutics, Inc. | 2 | $3,997 |
| Promega Corporation | 2 | $60 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,201 in reported general payments places this provider in the 95th percentile of 133 infectious disease providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Madison
- James LevinMadison$167K
- Robert StrikerMadison$80K
- Shravan KethireddyMadison$22K
- David AndesMadison$20K
- Barry FoxMadison$541
- Dawd SirajMadison$364
- Bradley SmithMadison$310
- John CherianMadison$259
- Amanda CarlsonMadison$146
- Mark MounajjedMadison$134
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.